Publication: An adverse effect of Ocrelizumab treatment in a patient with multiple sclerosis: a case report of necrotizing periodontitis
Authors
Montoya Carralero, José María ; Sánchez Pérez, Arturo Joaquín ; Jornet García, Alfonso Felipe ; Moya Villaescusa, María José
item.page.secondaryauthor
item.page.director
Publisher
Gavin Publishers
publication.page.editor
publication.page.department
DOI
https://doi.org/10.29011/2574-7347.100103
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Multiple Sclerosis (MS) and Necrotizing Periodontitis (NP) are two diseases whose aetiologies and pathophysiologies do not appear to have a common link; however, treating MS with monoclonal antibodies and the decrease in humoral immunity that this entails can be a trigger or an aggravation in patients who present with quiescent NP. We describe a clinical case of NP, including clinical manifestations, treatment, and evolution during therapy with ocrelizumab and to review risk factors. A rapid progression of NP was evidenced. During the patient’s evolution, she suffered bilateral pneumonia due to coronavirus disease 2019, requiring treatment with corticosteroids and antibiotics, which led to clinical relief of her NP. Based on this case, we believe that regulated dental monitoring of patients with MS before, during, and after the administration of monoclonal antibodies may help prevent periodontal deterioration.
publication.page.subject
Citation
Dentistry: Advanced Research, 2023, Vol.7 , N. 2: 203
item.page.embargo
Collections
Ir a Estadísticas
Este ítem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-sa/4.0/